A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05442788 · COMPLETED
Trial details
- NCT number
- NCT05442788
- Sponsor
- Huabo Biopharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2022-05-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.